Epitope binning immunoassays using Fiber Optic Particle Plasmon Resonance (FOPPR™) technology could be deployed in the development of new potential drug candidates. Furthermore, it could accommodate up to four mAbs in one experiment run, enabling this characterization process to be more time- and material efficient for scientists.
This webinar will discuss how FOPPR™ is used to characterize closely related “bins” of mAbs targeting the same epitope of the target protein and how the selection process is used in assay development. We also are pleased to invite AnTaimmuBioMed to share how they use FOPPR™ to develop COVID-19 related therapeutic antibodies and diagnostic tools.

Speakers:
Tony Chung (CEO of Instant NanoBiosensors)
Dr. Ing-Chien Chen (Head of R&D Department of AnTaimmu BioMed)

Topic: Epitope Binning: A Critical Step in Antibody Development
Date: 10th Dec. 2021
Time: 10:00am -10:45am CST
Contact mail: bd@instantnano.com

Register: https://us02web.zoom.us/webinar/register/WN_rMiDBmmjTFOyg3qHRDKSSQ